Figure 3From: Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acidPlasmid stabilities of transgenic yeast strains. EPY307 harbors pESC-Leu2d-T plasmid and EPY309 harbors pESC-Leu2d-TKO, which carries AMO inactivated by the C439G point mutation.Back to article page